Second Philippine Patent Granted!

The University of San Agustin โ€“ Center for Chemical Biology and Biotechnology and Center for Natural Drug Discovery and Development (USA โ€“ C2B2 & CND3) proudly celebrates another milestone achievement with the granting of its second Philippine patent, titled:

โ€œ๐˜”๐˜ฆ๐˜ต๐˜ฉ๐˜ฐ๐˜ฅ๐˜ด ๐˜ฐ๐˜ง ๐˜—๐˜ถ๐˜ณ๐˜ช๐˜ง๐˜บ๐˜ช๐˜ฏ๐˜จ ๐˜ˆ๐˜ฏ๐˜ต๐˜ช๐˜ฃ๐˜ช๐˜ฐ๐˜ต๐˜ช๐˜ค ๐˜Š๐˜ฐ๐˜ฎ๐˜ฑ๐˜ฐ๐˜ถ๐˜ฏ๐˜ฅ๐˜ด ๐˜ง๐˜ณ๐˜ฐ๐˜ฎ ๐˜Š๐˜ข๐˜ซ๐˜ข๐˜ฏ๐˜ถ๐˜ด ๐˜Š๐˜ข๐˜ซ๐˜ข๐˜ฏ.โ€

This patented technology describes a method for purifying antibiotic metabolites from kadios seeds, revealing their potential as natural agents against multidrug-resistant Staphylococcus aureus and other skin pathogens. The patent was granted on 10 October 2025 and is valid until 31 August 2042. Its protection strengthens the methodโ€™s commercial viability and supports future product development.